[Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
D000818:Animals; D000965:Antimony / Q000494:pharmacology / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006224:Cricetinae; D004359:Drug Therapy, Combination; D005260:Female; D007891:Leishmania / Q000187:drug effects; D007896:Leishmaniasis / Q000188:drug therapy*; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy*; D008297:Male; D008536:Meglumine; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds; D010303:Paromomycin / Q000494:pharmacology / Q000627:therapeutic use*; D012737:Sex Factors
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D010303:Paromomycin; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony
Quimioterapia experimental en leishmaniasis cutánea. III. Acción del glucantime y del humatín (P&D) sobre Leishmania garnhami y Leishmania braziliensis en hamsteres.